Lutheran Cancer Center brings leading breast cancer researcher to share latest advancements
All welcome to attend free presentation Oct. 24 on local and national research
FORT WAYNE, Ind. (Tuesday, Oct. 10, 2017) – Lutheran Cancer Center will host a nationally-recognized expert in the field of breast cancer care to address progress in breast cancer research on Tuesday, Oct. 24. Keynote speaker Dennis J. Slamon, MD, PhD, will be joined by a panel of local specialists at a free public forum called “Surviving and Thriving with HER2+ Breast Cancer.” This is the latest seminar in Lutheran Cancer Center’s New Directions series.
Dr. Slamon serves as director of clinical/translational research, and as a director of the Revlon/UCLA Women’s Cancer Research Program, at the UCLA Jonsson Comprehensive Cancer Center. For 12 years, Dr. Slamon and his colleagues conducted the laboratory and clinical research that led to the approval of the breast cancer drug Herceptin, which targets a specific genetic alteration found in about 25 percent of breast cancer patients.
The symposium will take place from 6:30 to 8:30 p.m. at Ceruti’s Banquet and Event Center, 6325 Illinois Road, and refreshments will be available starting at 5:45 p.m. Attendees are asked to register online at LutheranHealth.net/LCCseminar by Tuesday, Oct. 17.
Dr. Slamon’s presentation, “Molecular Diversity of Human Breast Cancers: Diagnostic and Therapeutic Implications,” will be followed by a 10-minute panelist Q&A with the audience.
Other presenters include:
• Tracy Hartzog, breast cancer survivor
• Pranil Chandra, DO, pathologist, PathGroup
“Genomic Profiling in Community Practice: Ensuring the Right Test for the Patient at the Right Time”
• Sunil Babu, MD, research director, Fort Wayne Medical Oncology and Hematology
“Update on Breast Cancer Research at the Lutheran Cancer Center”
The event is sponsored by Lutheran Cancer Center, Fort Wayne Medical Education Program and Fort Wayne Medical Oncology and Hematology.
“Use of Herceptin has really been a game-changer for women with HER2+ breast cancer,” said Rachael Hayes, MD, breast surgical oncologist, Lutheran Hospital. “This progressive cancer has become more manageable in no small part because of Dr. Slamon’s work.”
On a side note, Dr. Slamon’s breakthrough research on HER2+ breast cancer was featured in a film called “Living Proof.” The film’s trailer featuring Harry Connick Jr. can be viewed via this YouTube link:
Learn more about the seminar at LutheranHealth.net/LCCseminar. Lutheran Cancer Center offers multidisciplinary care coordinated with help of a certified nurse breast navigator. Find more information at LutheranHospital.com/breast-cancer-care, or call the Cancer Resource Center at (260) 435-7959.